Andere Sprachen LumiraDx Limited

Aktien

Markt geschlossen - OTC Markets Andere Börsenplätze 21:56:20 26.04.2024			% 5 Tage	% 1. Jan.
0,017 ^USD	+10,68 %		+4,29 %	-72,97 %

08.01.	Top-Mittagskursrückgänge	MT
02.01.	Wall Street eröffnet 2024 angesichts steigender Ölpreise und vor den Daten zum verarbeitenden Gewerbe und zum Baugewerbe schwächer	MT

Top Midday Decliners	08.01.
Stocks Commence 2024 Bullish Rally: LMDX, HNRC, BULT, HALB, SPZI	08.01.
LumiraDx Limited(OTCPK:LMDX.F) dropped from NASDAQ Composite Index	08.01.
LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th	05.01.
Wall Street Set to Open 2024 Lower Amid Rise in Oil Prices, Ahead of Manufacturing, Construction Data	02.01.
Top Premarket Decliners	02.01.
Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform	02.01.
Roche to buy part of LumiraDx diagnostics platform for $295 million	30.12.
LumiraDx Agrees to Sell Point-of-Care Tech Platform to Roche	29.12.
LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche	29.12.
LumiraDx : EXPLANATORY NOTE - Form 6-K	29.12.
LumiraDx : EXPLANATORY NOTE - Form 6-K	11.12.
Wall Street Set to Open Lower Friday as Investors Await Economic Data, Powell Speech	01.12.
Investors Look Ahead to Powell Speech as US Futures Trend Lower Friday	01.12.
Top Premarket Decliners	01.12.
LumiraDx : EXPLANATORY NOTE - Form 6-K	21.11.
LumiraDx Limited Announces Resignation of Lu Huang from the Board of Directors	07.11.
LumiraDx : EXPLANATORY NOTE - Form 6-K	06.11.
LumiraDx Limited Announces Board Appointments	06.11.
LumiraDx Limited Appoints Veronique Ameye as the Company?s Chief Executive Officer and General Counsel, Effective as of November 1, 2023	06.11.

Keine Ergebnisse zu dieser Suche